The Emerging Role of Nurse Practitioners in Physical Medicine and Rehabilitation
Nurse Practitioners can provide efficacious care to people with disabilities, resulting in cost savings, improved outcomes, and high value.
Pain Management Information Center
Contextual Effect Enhances Management of Knee Osteoarthritis
Researchers aimed to clarify the role of contextual effect in widely used nonpharmacologic, nonsurgical treatments for knee osteoarthritis by conducting a literature review of knee osteoarthritis trials.
Galcanezumab Linked to Improved Work Productivity in Patients With Migraine
Galcanezumab was found to significantly improve work productivity and reduce interictal burden in patients with treatment-resistant migraine, according to results from the phase 3 CONQUER study.
Positive Outcomes Reported With Novel Intranasal DHE for Migraine
Positive results were announced from the phase 3 STOP-301 study evaluating INP104 (intranasal dihydroergotamine mesylate; Impel NeuroPharma) for the treatment of acute migraine in adults.
Some Patients With Early-Stage Breast Cancer Found to Be at Risk of Prolonged Opioid Use After Surgery
Patients with early-stage breast cancer who undergo mastectomy with or without reconstruction are at risk of prolonged opioid use.
Prescription Drug Monitoring Programs May Prevent Patients With Cancer From Receiving Pain Management Therapy
Prescription drug monitoring programs that aim to prevent opioid misuse may be affecting patients with cancer who need pain management.
Repetitive Multiple Cranial Nerve Blocks Offer Effective Prevention for Chronic Migraine
Repetitive multiple cranial nerve blocks may offer a clinically meaningful benefit as a preventative measure in patients with chronic migraine.
FDA Clears Hand-Held Vagus Nerve Stimulator for Migraine Prevention
The FDA has approved an expanded indication for the gammaCore device to include prevention of migraine.
Prophylactic Manual Acupuncture Reduces Migraine Days
Undergoing 20 sessions of manual acupuncture is superior to sham acupuncture and usual care for prophylactic treatment in migraine.
Network Analysis Supports Targeting Patients’ Strengths to Treat Chronic Pain
Depression is twice as common in patients with chronic pain compared to health subjects, and pain intensity, frequency, and number of locations are linked to depression and anxiety.
DEA: 2020 Drugs of Abuse Resource Guide Now Available
The guide includes information on a drug’s origin, common street names, how it is abused, what effect it has on the mind and body, what the overdose effects are, and what its legal status is in the US.
AMA Releases Recommendations for Opioid Use Disorder, Pain During COVID-19
The AMA called for alterations for insurers, including terminating cost-sharing and prior authorization for chronic pain and OUD medications and removing restrictions on Medicaid preferred drug lists.
Intranasal Ketamine Reduces Pain in Children Hospitalized for Migraine
A single-center study showed that intranasal ketamine effectively reduced pain in children with migraine from hospital admission to discharge.
Drug Therapies Evaluated for Pediatric Migraine Prophylaxis
There is limited evidence supporting the prophylactic use of pharmacological therapies for the prevention of migraine in pediatric patients, according to the findings of a recently published systematic review and network meta-analysis.
Author Conflicts of Interest May Influence Cannabidiol Conclusions
Supportive conclusions seen in more studies with vs without CBD-related industry funding.
FDA Approves OTC Combination of Ibuprofen and Acetaminophen
Each caplet contains 125mg of Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) and 250mg of acetaminophen and is indicated for adults and children 12 years of age and older.
The Impact of Weight Loss on Migraine Characteristics in Patients With Obesity
Among patients with obesity and migraine, weight loss is associated with reduction of migraine frequency, pain severity, and attack duration and disability.
Nonpharmaceutical Interventions Aid Low Back Pain
Movement-based mind-body interventions could be effective alternatives to drugs, surgery, injections.
Kratom Seems Safe for Pain, Anxiety, Opioid Withdrawal
Kratom most commonly used daily; few serious adverse events self-reported among users.
Ubrogepant Works Quickly to Relieve Acute Migraine Pain
Ubrogepant, the newly approved calcitonin gene-related peptide antagonist, can relieve migraine symptoms within 2 hours after initial dose.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Pain Management Information Center
